Characteristics of benign and malignant ITNs that undergo surgery
| Benign ITN | Malignant ITN | All ITN | P Value | |
|---|---|---|---|---|
| Agea | 58 ± 14 | 54 ± 13 | 56 ± 14 | .3 |
| Sex | ||||
| Female | 16 (67) | 19 (83) | 35 (74) | .3b |
| Male | 8 (33) | 4 (17) | 12 (26) | |
| Nodule size (in mm) | ||||
| Imaginga | 22 ± 13 | 17 ± 7 | 20 ± 11 | .2 |
| Pathology | NA | 14 ± 8 | NA | |
| Imaging modality on which ITN was detected | .2b,c | |||
| CT | 9 (38) | 13 (57) | 22 (47) | |
| PET/CT | 4 (17) | 6 (26) | 10 (21) | |
| Ultrasound | 7 (29) | 2 (9) | 9 (19) | |
| MRI | 3 (13) | 1 (4) | 4 (9) | |
| Chest radiograph | 1 (4) | 0 | 1 (2) | |
| Echocardiogram | 0 | 1 (4) | 1 (2) | |
| Cytology | <.001b,d | |||
| I—Nondiagnostic or unsatisfactory | 2 (8) | 1 (4) | 3 (6) | |
| II—Benign | 2 (8) | 0 | 2 (4) | |
| III—Atypia of undetermined significance/follicular lesion of undetermined significance | 10 (42) | 1 (4) | 11 (23) | |
| IV—Follicular neoplasm/suspicious for follicular neoplasm | 8 (33) | 1 (4) | 9 (19) | |
| V—Suspicious for malignancy | 2 (8) | 6 (26) | 8 (17) | |
| VI—Malignant | 0 | 14 (61) | 14 (30) | |
| Total | 24 | 23 | 47 |
Note:—Unless otherwise specified, data are numbers of patients, with percentages in parentheses. Percentages may not add up to 100% due to rounding.
↵a Data reported as mean ± standard deviation.
↵b Calculated with Fisher exact test.
↵c For CT versus other imaging modalities.
↵d For diagnostic categories I, II, and II versus IV, V, and VI.